You forgot about Novel? The asset to Elite which is worth several times their entire Debt? You said they had tons of debt and no assets but the fact is Novel is worth much more then their entire debt. Is that why you have held your shares while making these claims for over a year?
This Novel
Novel has an aggressive pipeline forecasting 10 to 12 ANDA approvals and product launches per year. In its first year alone, Novel filed 8 ANDAs with the USFDA. Currently, Novel has identified over 50 drug products which are in various stages of development to be commercialized in the coming years. As a tenacious first-to-file generic comapany, Novel is continuously pursuing first-to-file & first-to-market opportunities and to date has been awarded 5 first-to-files while awaiting 2 more.
Novel currently has over 20 ANDAs with the USFDA. 5 of those applications have been approved and 3 have received tentative approvals. To supplement its considerable in-house R&D capabilities, Novel has acquired 8 additional ANDAs from other firms for manufacturing and marketing.
Market Data 
Markets 
AI
